Skip to main content
  • Saved

made a Post

BRD7 increases resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer - PubMed

BRD7 increases resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/34477353/

doi: 10.23736/S0026-4806.21.07716-8. Online ahead of print. 1 Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. 2 Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. 3 Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China - [email protected]